These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15289736

  • 1. Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).
    Bellon JR, Livingston RB, Eubank WB, Gralow JR, Ellis GK, Dunnwald LK, Mankoff DA.
    Am J Clin Oncol; 2004 Aug; 27(4):407-10. PubMed ID: 15289736
    [Abstract] [Full Text] [Related]

  • 2. 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
    Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ, Gralow JR, Charlop A, Ellis GK, Lindsley KL, Austin-Seymour MM, Funkhouser CP, Livingston RB.
    J Clin Oncol; 2001 Aug 01; 19(15):3516-23. PubMed ID: 11481358
    [Abstract] [Full Text] [Related]

  • 3. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M.
    J Natl Cancer Inst; 1996 Sep 04; 88(17):1204-9. PubMed ID: 8780629
    [Abstract] [Full Text] [Related]

  • 4. (18)F-FDG PET/CT-positive internal mammary lymph nodes: pathologic correlation by ultrasound-guided fine-needle aspiration and assessment of associated risk factors.
    Wang CL, Eissa MJ, Rogers JV, Aravkin AY, Porter BA, Beatty JD.
    AJR Am J Roentgenol; 2013 May 04; 200(5):1138-44. PubMed ID: 23617501
    [Abstract] [Full Text] [Related]

  • 5. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Singh B, Singh G.
    Hell J Nucl Med; 2011 May 04; 14(2):135-9. PubMed ID: 21761015
    [Abstract] [Full Text] [Related]

  • 6. 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.
    Baslaim MM, Bakheet SM, Bakheet R, Ezzat A, El-Foudeh M, Tulbah A.
    World J Surg; 2003 Oct 04; 27(10):1099-104. PubMed ID: 12917770
    [Abstract] [Full Text] [Related]

  • 7. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
    Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T.
    Indian J Med Res; 2018 Mar 04; 147(3):256-262. PubMed ID: 29923514
    [Abstract] [Full Text] [Related]

  • 8. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
    van der Hoeven JJ, Krak NC, Hoekstra OS, Comans EF, Boom RP, van Geldere D, Meijer S, van der Wall E, Buter J, Pinedo HM, Teule GJ, Lammertsma AA.
    J Clin Oncol; 2004 Apr 01; 22(7):1253-9. PubMed ID: 15051773
    [Abstract] [Full Text] [Related]

  • 9. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
    Wahl RL, Siegel BA, Coleman RE, Gatsonis CG, PET Study Group.
    J Clin Oncol; 2004 Jan 15; 22(2):277-85. PubMed ID: 14722036
    [Abstract] [Full Text] [Related]

  • 10. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T, Yajima R, Tatsuki H, Kuwano H.
    Anticancer Res; 2016 Apr 15; 36(4):1785-9. PubMed ID: 27069160
    [Abstract] [Full Text] [Related]

  • 11. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP, David S, Alamgeer M, Ganju V.
    Int J Radiat Oncol Biol Phys; 2015 Sep 01; 93(1):111-7. PubMed ID: 26279029
    [Abstract] [Full Text] [Related]

  • 12. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
    Ahn JH, Son EJ, Kim JA, Youk JH, Kim EK, Kwak JY, Ryu YH, Jeong J.
    Acta Radiol; 2010 Oct 01; 51(8):859-65. PubMed ID: 20670083
    [Abstract] [Full Text] [Related]

  • 13. Dual time point 2-deoxy-2-[18F]fluoro-D-glucose PET/CT: nodal staging in locally advanced breast cancer.
    García Vicente AM, Soriano Castrejón A, Cruz Mora MÁ, Ortega Ruiperez C, Espinosa Aunión R, León Martín A, González Ageitos A, Van Gómez López O.
    Rev Esp Med Nucl Imagen Mol; 2014 Oct 01; 33(1):1-5. PubMed ID: 23707190
    [Abstract] [Full Text] [Related]

  • 14. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB, Mankoff DA, Maravilla KR, Austin-Seymour MM, Ellis GK, Gralow JR, Cortese AA, Hayes CE, Moe RE.
    Radiology; 1999 Mar 01; 210(3):807-14. PubMed ID: 10207485
    [Abstract] [Full Text] [Related]

  • 15. Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT.
    Evangelista L, Cervino AR, Michieletto S, Saibene T, Orvieto E, Bozza F, Ghiotto C.
    Q J Nucl Med Mol Imaging; 2017 Jun 01; 61(2):205-215. PubMed ID: 25501326
    [Abstract] [Full Text] [Related]

  • 16. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
    Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R, Micheli A, Asero S, Ferraris C, Gennaro M, Bombardieri E, Cascinelli N.
    J Natl Cancer Inst; 2001 Apr 18; 93(8):630-5. PubMed ID: 11309439
    [Abstract] [Full Text] [Related]

  • 17. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.
    Schirrmeister H, Kühn T, Guhlmann A, Santjohanser C, Hörster T, Nüssle K, Koretz K, Glatting G, Rieber A, Kreienberg R, Buck AC, Reske SN.
    Eur J Nucl Med; 2001 Mar 18; 28(3):351-8. PubMed ID: 11315604
    [Abstract] [Full Text] [Related]

  • 18. The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer.
    Danforth DN, Aloj L, Carrasquillo JA, Bacharach SL, Chow C, Zujewski J, Whatley M, Galen B, Merino M, Neumann RD.
    Breast Cancer Res Treat; 2002 Sep 18; 75(2):135-46. PubMed ID: 12243506
    [Abstract] [Full Text] [Related]

  • 19. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E.
    Eur J Nucl Med Mol Imaging; 2004 Jun 18; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [Abstract] [Full Text] [Related]

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Jun 18; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.